Massive companies, often referred to as mega-cap stocks, tend to shape their industries thanks to their significant size, which usually provides them with robust competitive advantages. But there’s a flip side: these companies often exhaust current market opportunities, and any further growth can require hefty investments, making it a bit of a gamble.
These challenges can be tricky, even for seasoned investors. That’s why StockStory was created – to help you identify quality companies that can still thrive financially, regardless of broader market conditions. With that context, let’s explore two industry titans known for their competitive edges and a third company that has room for growth due to its established products.
Market capitalization: $224.3 billion
GE Vernova (NYSE: GEV), which emerged from General Electric’s energy sector in 2023, focuses on designing and servicing equipment for power generation and grid technology. This helps clients enhance the reliability and sustainability of their power systems.
Why is GEV facing challenges?
-
The company’s size can be a drawback; it hampers growth potential versus smaller competitors, shown in its less-than-stellar annual revenue growth of 3.6% over the past four years.
-
The gross profit margin sits at 16.2%, indicating high production costs.
-
Ongoing losses in operating margins point to weaknesses in managing expenses.
Currently, GE Vernova’s stock trades at $831.75 per share, with a forward price-to-earnings (P/E) ratio of 60.2.
Market capitalization: $1.59 trillion
Broadcom (NASDAQ: AVGO), originally part of Hewlett-Packard’s semiconductor division, operates across various sectors, including infrastructure software, cybersecurity, wireless communications, and data storage.
What drives AVGO’s success?
-
Over the last two years, its annual revenue growth has been impressive at 32.5%, a sign of gaining market share.
-
Producing its products at scale is quite challenging, resulting in exceptional gross margins of 76.5%.
-
AVGO generates significant free cash flow, allowing it to invest in growth and reward shareholders.
Broadcom’s stock, currently priced at $336.24, has a forward P/E ratio of 25.6. This brings up the question: is this a good time to buy?
Market capitalization: $198.3 billion
Founded in 1980 during the early years of the biotechnology revolution, Amgen (NASDAQ: AMGN) is dedicated to creating innovative treatments for serious ailments like cancer, osteoporosis, and autoimmune disorders.
What makes AMGN stand out?
-
With an annual revenue growth of 14.2% in the past two years, it exceeds the industry average, highlighting its unique service offerings.
-
Its revenue base of $36.75 billion affords economies of scale and increased bargaining power.
-
A healthy free cash flow margin of 28.6% allows for ongoing investment and capital returns.
Amgen’s stock price is $368.37 per share, and it carries a forward P/E ratio of 16.8. One wonders if this is the right moment to invest.
Lastly, consider the top 5 growth stocks. Typically, the most successful stocks share a common trait – rapidly increasing revenues. Companies like Meta and Broadcom have been highlighted, with returns soaring between 314% and 455%.
Explore the trending stocks this month. You might find something worthwhile.
This list of stocks from 2020 includes well-known players like Nvidia, which has skyrocketed by 1,326%, as well as lesser-known firms like Technoglass, soaring by 1,754% in five years.
